Corix Bioscience, Inc. (CXBS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST

Corix Bioscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2016 FY 2015
Period Ending
Dec '16 Dec '15
Revenue
0.690.48
Revenue Growth (YoY)
43.78%-
Gross Profit
0.690.48
Net Income
-4.43-2.77
Gross Margin
100.00%100.00%
Profit Margin
-638.63%-573.44%
Source: S&P Capital IQ. Standard template. Financial Sources.